66 research outputs found
Rapid and sustained nuclear–cytoplasmic ERK oscillations induced by epidermal growth factor
Although the ERK pathway has a central role in the response of cells to growth factors, its regulatory structure and dynamics are incompletely understood. To investigate ERK activation in real time, we expressed an ERK–GFP fusion protein in human mammary epithelial cells. On EGF stimulation, we observed sustained oscillations of the ERK–GFP fusion protein between the nucleus and cytoplasm with a periodicity of ∼15 min. The oscillations were persistent (>45 cycles), independent of cell cycle phase, and were highly dependent on cell density, essentially disappearing at confluency. Oscillations occurred even at ligand doses that elicited very low levels of ERK phosphorylation, and could be detected biochemically in both transfected and nontransfected cells. Mathematical modeling revealed that negative feedback from phosphorylated ERK to the cascade input was necessary to match the robustness of the oscillation characteristics observed over a broad range of ligand concentrations. Our characterization of single-cell ERK dynamics provides a quantitative foundation for understanding the regulatory structure of this signaling cascade
Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution
<p>Abstract</p> <p>Background</p> <p>Group B <it>Streptococcus </it>(GBS) serotype (Ia, Ib, II-IX) correlates with pathogen virulence and clinical prognosis. Epidemiological studies of seroprevalence are an important metric for determining the proportion of serotypes in a given population. The purpose of this study was to evaluate the prevalence of individual GBS serotypes at Madigan Healthcare System (Madigan), the largest military tertiary healthcare facility in the Pacific Northwestern United States, and to compare seroprevalences with international locations.</p> <p>Methods</p> <p>To determine serotype distribution at Madigan, we obtained GBS isolates from standard-of-care anogenital swabs from 207 women of indeterminate gravidity between ages 18-40 during a five month interval. Serotype was determined using a recently described molecular method of polymerase chain reaction by capsular polysaccharide synthesis (cps) genes associated with pathogen virulence.</p> <p>Results</p> <p>Serotypes Ia, III, and V were the most prevalent (28%, 27%, and 17%, respectively). A systematic review of global GBS seroprevalence, meta-analysis, and statistical comparison revealed strikingly similar serodistibution at Madigan relative to civilian-sector populations in Canada and the United States. Serotype Ia was the only serotype consistently higher in North American populations relative to other geographic regions (p < 0.005). The number of non-typeable isolates was significantly lower in the study (p < 0.005).</p> <p>Conclusion</p> <p>This study establishes PCR-based serotyping as a viable strategy for GBS epidemiological surveillance. Our results suggest that GBS seroprevalence remains stable in North America over the past two decades.</p
Alterations in tissue microRNA after heat stress in the conscious rat: potential biomarkers of organ-specific injury
Abstract Background Heat illness remains a significant cause of morbidity in susceptible populations. Recent research elucidating the cellular mechanism of heat stress leading to heat illness may provide information to develop better therapeutic interventions, risk assessment strategies, and early biomarkers of organ damage. microRNA (miRNA) are promising candidates for therapeutic targets and biomarkers for a variety of clinical conditions since there is the potential for high specificity for individual tissues and unique cellular functions. The objective of this study was to identify differentially expressed microRNAs and their putative mRNA targets in the heart, liver, kidney, and lung in rats at three time points: during heat stress (i.e., when core temperature reached 41.8 °C), or following a 24 or 48 h recovery period. Results Rats did not show histological evidence of tissue pathology until 48 h after heat stress, with 3 out of 6 rats showing cardiac inflammation and renal proteinosis at 48 h. The three rats with cardiac and renal pathology had 86, 7, 159, and 37 differentially expressed miRNA in the heart, liver, kidney, or lung, respectively compared to non-heat stressed control animals. During heat stress one differentially expressed miRNA was found in the liver and five in the lung, with no other modulated miRNA after 24 h or 48 h in animals with no evidence of organ injury. Pathway enrichment analysis revealed enrichment in functional pathways associated with heat stress, with the greatest effects observed in animals with histological evidence of cardiac and renal damage at 48 h. Inhibiting miR-21 in cultured cardiomyocytes increased the percent apoptotic cells five hours after heat stress from 70.9 ± 0.8 to 84.8 ± 2.2%. Conclusions Global microRNA and transcriptomics analysis suggested that perturbed miRNA due to heat stress are involved in biological pathways related to organ injury, energy metabolism, the unfolded protein response, and cellular signaling. These miRNA may serve as biomarkers of organ injury and potential pharmacological targets for preventing heat illness or organ injury
Predicting Rat and Human Pregnane X Receptor Activators Using Bayesian Classification Models
The
pregnane X receptor (PXR) is a ligand-activated transcription
factor that acts as a master regulator of metabolizing enzymes and
transporters. To avoid adverse drug–drug interactions and diseases
such as steatosis and cancers associated with PXR activation, identifying
drugs and chemicals that activate PXR is of crucial importance. In
this work, we developed ligand-based predictive computational models
for both rat and human PXR activation, which allowed us to identify
potentially harmful chemicals and evaluate species-specific effects
of a given compound. We utilized a large publicly available data set
of nearly 2000 compounds screened in cell-based reporter gene assays
to develop Bayesian quantitative structure–activity relationship
models using physicochemical properties and structural descriptors.
Our analysis showed that PXR activators tend to be hydrophobic and
significantly different from nonactivators in terms of their physicochemical
properties such as molecular weight, logP, number of rings, and solubility.
Our Bayesian models, evaluated by using 5-fold cross-validation, displayed
a sensitivity of 75% (76%), specificity of 76% (75%), and accuracy
of 89% (89%) for human (rat) PXR activation. We identified structural
features shared by rat and human PXR activators as well as those unique
to each species. We compared rat <i>in vitro</i> PXR activation
data to <i>in vivo</i> data by using DrugMatrix, a large
toxicogenomics database with gene expression data obtained from rats
after exposure to diverse chemicals. Although <i>in vivo</i> gene expression data pointed to cross-talk between nuclear receptor
activators that is captured only by <i>in vivo</i> assays,
overall we found broad agreement between <i>in vitro</i> and <i>in vivo</i> PXR activation. Thus, the models developed
here serve primarily as efficient initial high-throughput <i>in silico</i> screens of <i>in vitro</i> activity
Predicting Rat and Human Pregnane X Receptor Activators Using Bayesian Classification Models
The
pregnane X receptor (PXR) is a ligand-activated transcription
factor that acts as a master regulator of metabolizing enzymes and
transporters. To avoid adverse drug–drug interactions and diseases
such as steatosis and cancers associated with PXR activation, identifying
drugs and chemicals that activate PXR is of crucial importance. In
this work, we developed ligand-based predictive computational models
for both rat and human PXR activation, which allowed us to identify
potentially harmful chemicals and evaluate species-specific effects
of a given compound. We utilized a large publicly available data set
of nearly 2000 compounds screened in cell-based reporter gene assays
to develop Bayesian quantitative structure–activity relationship
models using physicochemical properties and structural descriptors.
Our analysis showed that PXR activators tend to be hydrophobic and
significantly different from nonactivators in terms of their physicochemical
properties such as molecular weight, logP, number of rings, and solubility.
Our Bayesian models, evaluated by using 5-fold cross-validation, displayed
a sensitivity of 75% (76%), specificity of 76% (75%), and accuracy
of 89% (89%) for human (rat) PXR activation. We identified structural
features shared by rat and human PXR activators as well as those unique
to each species. We compared rat <i>in vitro</i> PXR activation
data to <i>in vivo</i> data by using DrugMatrix, a large
toxicogenomics database with gene expression data obtained from rats
after exposure to diverse chemicals. Although <i>in vivo</i> gene expression data pointed to cross-talk between nuclear receptor
activators that is captured only by <i>in vivo</i> assays,
overall we found broad agreement between <i>in vitro</i> and <i>in vivo</i> PXR activation. Thus, the models developed
here serve primarily as efficient initial high-throughput <i>in silico</i> screens of <i>in vitro</i> activity
Vitamin D deficiency in early pregnancy.
Vitamin D deficiency is a common problem in reproductive-aged women in the United States. The effect of vitamin D deficiency in pregnancy is unknown, but has been associated with adverse pregnancy outcomes. The objective of this study was to analyze the relationship between vitamin D deficiency in the first trimester and subsequent clinical outcomes.This is a retrospective cohort study. Plasma was collected in the first trimester from 310 nulliparous women with singleton gestations without significant medical problems. Competitive enzymatic vitamin D assays were performed on banked plasma specimens and pregnancy outcomes were collected after delivery. Logistic regression was performed on patients stratified by plasma vitamin D concentration and the following combined clinical outcomes: preeclampsia, preterm delivery, intrauterine growth restriction, gestational diabetes, and spontaneous abortion.Vitamin D concentrations were obtained from 235 patients (mean age 24.3 years, range 18-40 years). Seventy percent of our study population was vitamin D insufficient with a serum concentration less than 30 ng/mL (mean serum concentration 27.6 ng/mL, range 13-71.6 ng/mL). Logistic regression was performed adjusting for age, race, body mass index, tobacco use, and time of year. Adverse pregnancy outcomes included preeclampsia, growth restriction, preterm delivery, gestational diabetes, and spontaneous abortion. There was no association between vitamin D deficiency and composite adverse pregnancy outcomes with an adjusted odds ratio of 1.01 (p value 0.738, 95% confidence intervals 0.961-1.057).Vitamin D deficiency did not associate with adverse pregnancy outcomes in this study population. However, the high percentage of affected individuals highlights the prevalence of vitamin D deficiency in young, reproductive-aged women
Genome-wide gene expression profiling of acute metal exposures in male zebrafish
To capture global responses to metal poisoning and mechanistic insights into metal toxicity, gene expression changes were evaluated in whole adult male zebrafish following acute 24 h high dose exposure to three metals with known human health risks. Male adult zebrafish were exposed to nickel chloride, cobalt chloride or sodium dichromate at concentrations corresponding to their respective 96 h LC20, LC40 and LC60 (i.e. 96 h concentrations at which 20%, 40% and 60% lethality is expected, respectively). Histopathology was performed on a subset of metal-exposed zebrafish to phenotypically anchor transcriptional changes associated with each metal exposure. Here we describe in detail the contents and quality controls for the gene expression and other data associated with the study published by Hussainzada and colleagues in BMC Pharmacology and Toxicology (Hussainzada et al., 2014) with the data uploaded to Gene Expression Omnibus (accession number GSE50648)
Identifying a predictive gene signature and signaling networks/pathways associated with acute kidney injury
Poster presented in SOT 2016<div><br></div><div>Understanding the molecular mechanisms
and signaling networks of acute kidney injury (AKI) will aid in biomarker
development. In this study, we carried out co-expression-based analyses of
DrugMatrix, a toxicogenomics database with kidney gene expression data from
rats after exposure to diverse chemicals. We used the iterative signature
algorithm and exhaustively generated modules using 50 different parameter
combinations. We clustered the modules using gene and condition overlap scores
and obtained 16 module clusters. Two of the module clusters showed activation
in chemical exposures causing kidney injury and mapped well-known AKI marker
genes such as <i>Havcr1</i>, <i>Tff3,</i> and <i>Clu</i>. We used the genes in these AKI-relevant module clusters to
develop a signature of 30 genes that could assess the potential of a chemical
to cause kidney injury well before injury actually occurs. We integrated
AKI-relevant module cluster genes with protein-protein interaction networks and
identified the involvement of immunoproteasomes in AKI. To identify biological
networks and processes linked to <em>Havcr1</em>, we determined genes
within the modules that frequently co-express with <em>Havcr1</em>,
including <em>Cd44</em>, <em>Plk2</em>, <em>Mdm2</em>, <em>Hnmt</em>, <em>Macrod1</em>,
and <em>Gtpbp4</em>. In this gene set,
CD44 is a potential non-invasive biomarker candidate as it is up-regulated
during AKI, undergoes cleavage of its ectodomain, and is secreted in urine. Overall, our analysis shows data mining of toxicological big data and
identification of new insights/biomarker candidates for acute kidney injury.</div
Longitudinal Proteomic Analysis of Plasma across Healthy Pregnancies Reveals Indicators of Gestational Age
Longitudinal changes in the blood proteome during gestation relate to fetal development and maternal homeostasis. Charting the maternal blood proteome in normal pregnancies is critical for establishing a baseline reference when assessing complications and disease. Using mass spectrometry-based shotgun proteomics, we surveyed the maternal plasma proteome across uncomplicated pregnancies. Results indicate a significant rise in proteins that govern placentation and are vital to the development and health of the fetus. Importantly, we uncovered proteome signatures that strongly correlated with gestational age. Fold increases and correlations between the plasma concentrations of ADAM12 (ρ = 0.973), PSG1 (ρ = 0.936), and/or CSH1/2 (ρ = 0.928) with gestational age were validated with ELISA. Proteomic and validation analyses demonstrate that the maternal plasma concentration of ADAM12, either independently or in combination with either PSG1 or CSH1/2, correlates with gestational age within ±8 days throughout pregnancy. These findings suggest that the gestational age in healthy pregnancies may be determined by referencing the concentration of select plasma proteins
Recommended from our members
Repeated exposure to neurotoxic levels of chlorpyrifos alters hippocampal expression of neurotrophins and neuropeptides.
Chlorpyrifos (CPF), an organophosphorus pesticide (OP), is one of the most widely used pesticides in the world. Subchronic exposures to CPF that do not cause cholinergic crisis are associated with problems in cognitive function (i.e., learning and memory deficits), but the biological mechanism(s) underlying this association remain speculative. To identify potential mechanisms of subchronic CPF neurotoxicity, adult male Long Evans (LE) rats were administered CPF at 3 or 10mg/kg/d (s.c.) for 21 days. We quantified mRNA and non-coding RNA (ncRNA) expression profiles by RNA-seq, microarray analysis and small ncRNA sequencing technology in the CA1 region of the hippocampus. Hippocampal slice immunohistochemistry was used to determine CPF-induced changes in protein expression and localization patterns. Neither dose of CPF caused overt clinical signs of cholinergic toxicity, although after 21 days of exposure, cholinesterase activity was decreased to 58% or 13% of control levels in the hippocampus of rats in the 3 or 10mg/kg/d groups, respectively. Differential gene expression in the CA1 region of the hippocampus was observed only in the 10mg/kg/d dose group relative to controls. Of the 1382 differentially expressed genes identified by RNA-seq and microarray analysis, 67 were common to both approaches. Differential expression of six of these genes (Bdnf, Cort, Crhbp, Nptx2, Npy and Pnoc) was verified in an independent CPF exposure study; immunohistochemistry demonstrated that CRHBP and NPY were elevated in the CA1 region of the hippocampus at 10mg/kg/d CPF. Gene ontology enrichment analysis suggested association of these genes with receptor-mediated cell survival signaling pathways. miR132/212 was also elevated in the CA1 hippocampal region, which may play a role in the disruption of neurotrophin-mediated cognitive processes after CPF administration. These findings identify potential mediators of CPF-induced neurobehavioral deficits following subchronic exposure to CPF at a level that inhibits hippocampal cholinesterase to less than 20% of control. An equally significant finding is that subchronic exposure to CPF at a level that produces more moderate inhibition of hippocampal cholinesterase (approximately 50% of control) does not produce a discernable change in gene expression
- …